Jun Zhu
Shanghai Medical College of Fudan University(CN)Nantong University(CN)Peking University(CN)China University of Geosciences(CN)Soochow University(CN)Fudan University Shanghai Cancer Center(CN)Peking University Cancer Hospital(CN)Taizhou Second People's Hospital(CN)Taizhou People's Hospital(CN)Ministry of Education(ET)First Affiliated Hospital of Soochow University(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Endometrial and Cervical Cancer Treatments, Chronic Lymphocytic Leukemia Research, Cervical Cancer and HPV Research
Most-Cited Works
- → Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy(2014)231 cited
- → Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study(2018)135 cited
- → circCELSR1 (hsa_circ_0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252(2019)130 cited
- → Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group(2013)121 cited
- → Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer(2018)117 cited